Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Behavioral Therapy in Combination With Drug-Darifenacin for Symptoms of Overactive Bladder

NCT00127270 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00127270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00127270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Behavioral Therapy in Combination With Drug-Darifenacin for Symptoms of Overactive Bladder
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
February 28, 2006
Enrollment
395 (actual)
Sites
67

Conditions

As the registry lists them; a condition with its own page is linked.

urinary incontinence